Agentix Corp. completes merger with Applied Biopharma LLC; interests converted to common stock

Agentix Corp.

Merger completed July 14, 2021: AB Merger LLC merged into Applied Biopharma, with Applied Biopharma surviving.
Each Applied Biopharma LLC interest was converted into one share of Agentix common stock ($0.001 par).
Articles of Merger filed with Nevada Secretary of State on July 14, 2021.
Merger Agreement dated July 13, 2021, previously filed as Exhibit 2.1 to a July 14, 2021 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.